Psyence Group Inc. (CSE:PSYG)

Market Cap	1.41M
Revenue (ttm)	n/a
Net Income (ttm)	-65.83M
Shares Out	9.39M
EPS (ttm)	-7.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,020
Average Volume	6,286
Open	0.1500
Previous Close	0.1550
Day's Range	0.1400 - 0.1500
52-Week Range	0.1050 - 0.5250
Beta	1.37
RSI	41.08
Earnings Date	Jul 30, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PSYG